Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1988 1
1990 3
1991 3
1992 3
1993 6
1994 3
1995 4
1996 3
1997 8
1998 6
1999 6
2000 3
2001 4
2002 5
2003 2
2004 4
2005 3
2006 6
2007 3
2008 2
2009 3
2010 1
2011 4
2012 2
2013 3
2015 1
2016 1
2020 1
2023 0
Text availability
Article attribute
Article type
Publication date

Search Results

91 results
Results by year
Filters applied: . Clear all
Page 1
Glutamate receptors and pain.
Bleakman D, Alt A, Nisenbaum ES. Bleakman D, et al. Semin Cell Dev Biol. 2006 Oct;17(5):592-604. doi: 10.1016/j.semcdb.2006.10.008. Epub 2006 Oct 28. Semin Cell Dev Biol. 2006. PMID: 17110139 Review.
Calcium influx and neurodegeneration.
Gibbons SJ, Brorson JR, Bleakman D, Chard PS, Miller RJ. Gibbons SJ, et al. Among authors: bleakman d. Ann N Y Acad Sci. 1993 May 28;679:22-33. doi: 10.1111/j.1749-6632.1993.tb18286.x. Ann N Y Acad Sci. 1993. PMID: 8390144 Review. No abstract available.
Kainate receptor pharmacology and physiology.
Bleakman D. Bleakman D. Cell Mol Life Sci. 1999 Nov 15;56(7-8):558-66. doi: 10.1007/s000180050453. Cell Mol Life Sci. 1999. PMID: 11212306 Review.
AMPA receptor potentiators as novel antidepressants.
Alt A, Witkin JM, Bleakman D. Alt A, et al. Among authors: bleakman d. Curr Pharm Des. 2005;11(12):1511-27. doi: 10.2174/1381612053764814. Curr Pharm Des. 2005. PMID: 15892659 Review.
Neuropharmacology of AMPA and kainate receptors.
Bleakman D, Lodge D. Bleakman D, et al. Neuropharmacology. 1998 Oct-Nov;37(10-11):1187-204. doi: 10.1016/s0028-3908(98)00139-7. Neuropharmacology. 1998. PMID: 9849657 Review. No abstract available.
TRP channels as emerging targets for pain therapeutics.
Broad LM, Mogg AJ, Beattie RE, Ogden AM, Blanco MJ, Bleakman D. Broad LM, et al. Among authors: bleakman d. Expert Opin Ther Targets. 2009 Jan;13(1):69-81. doi: 10.1517/14728220802616620. Expert Opin Ther Targets. 2009. PMID: 19063707 Review.
A 'BOLD' experiment in defining the utility of fMRI in drug development.
Borsook D, Bleakman D, Hargreaves R, Upadhyay J, Schmidt KF, Becerra L. Borsook D, et al. Among authors: bleakman d. Neuroimage. 2008 Aug 15;42(2):461-6. doi: 10.1016/j.neuroimage.2008.04.268. Epub 2008 Jun 10. Neuroimage. 2008. PMID: 18598770 Review. No abstract available.
Decision-making using fMRI in clinical drug development: revisiting NK-1 receptor antagonists for pain.
Borsook D, Upadhyay J, Klimas M, Schwarz AJ, Coimbra A, Baumgartner R, George E, Potter WZ, Large T, Bleakman D, Evelhoch J, Iyengar S, Becerra L, Hargreaves RJ. Borsook D, et al. Among authors: bleakman d. Drug Discov Today. 2012 Sep;17(17-18):964-73. doi: 10.1016/j.drudis.2012.05.004. Epub 2012 May 10. Drug Discov Today. 2012. PMID: 22579743 Review.
91 results